作者 Lee, Jun; Jang, Dae Sik; Kim, Nan Hee; Lee, Yun Mi; Kim, Junghyun; Kim, Jin Sook
期刊 BIOLOGICAL & PHARMACEUTICAL BULLETIN , MAR 2011,3:34
DOI 10.1248/bpb.34.443 PubMed 21372401
摘要 In an ongoing project directed toward the discovery of novel treatments for diabetic complications from traditional herbal medicines, six galloyl glucoses, 1,2,3-tri-O-galloyl-beta-D-glucose (1), 1,2,6-tri-O-galloyl-beta-D-glucose (2), 1,2,3,6-tetra-O-galloyl-beta-D-glucose (3), 1,2,4,6-tetra-O-galloyl-beta-D-glucose (4), 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (5), and tellimagrandin II (6), and two phenolic acids, gallic acid 4-O-beta-D-glucoside (7) and gallic acid 4-O-beta-D-(6''-O-galloyl)-glucoside (8), were isolated from an EtOAc-soluble fraction of the seeds of Cornus officinalis (Cornaceae). The structures of the compounds were identified using physical and spectroscopic methods, as well as by comparison of their data with values reported in the literature. All the isolates were evaluated in vitro for inhibitory activity against the formation of advanced glycation end-products (AGEs) and rat lens aldose reductase (RLAR). Compounds 1-6 were subjected to further bioassay to examine their inhibitory effects on AGE cross-linking. The opacity of lenses was significantly prevented when treated with 3 in an ex vivo experiment.
版权所有 Copyright © 2002-2025 中国科学院昆明植物研究所,All Rights Reserved 【滇ICP备05000394号】
地址:中国云南省昆明市蓝黑路132号 邮政编码:650201 点击这里联系我们